vs

Side-by-side financial comparison of Becton Dickinson (BDX) and NewGenIvf Group Ltd (NIVF). Click either name above to swap in a different company.

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.

NewGenIvf Group Ltd is a specialized assisted reproductive technology (ART) service provider. It offers a full range of fertility solutions including in vitro fertilization, preimplantation genetic testing and fertility preservation, primarily serving clients across Greater China and Southeast Asia, including both local and cross-border patients seeking reproductive care.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDX
BDX
NIVF
NIVF
Q4 25
$5.3B
Q3 25
$5.9B
Q2 25
$5.5B
Q1 25
$5.3B
Q4 24
$5.2B
Q3 24
$5.4B
Q2 24
$5.0B
Q1 24
$5.0B
Net Profit
BDX
BDX
NIVF
NIVF
Q4 25
$382.0M
Q3 25
$493.0M
Q2 25
$574.0M
Q1 25
$308.0M
Q4 24
$303.0M
Q3 24
$400.0M
Q2 24
$487.0M
Q1 24
$537.0M
Gross Margin
BDX
BDX
NIVF
NIVF
Q4 25
45.9%
Q3 25
47.5%
Q2 25
47.8%
Q1 25
42.8%
Q4 24
43.2%
Q3 24
45.7%
Q2 24
46.2%
Q1 24
45.7%
Operating Margin
BDX
BDX
NIVF
NIVF
Q4 25
10.5%
Q3 25
11.8%
Q2 25
16.0%
Q1 25
10.4%
Q4 24
8.8%
Q3 24
11.4%
Q2 24
12.1%
Q1 24
14.5%
Net Margin
BDX
BDX
NIVF
NIVF
Q4 25
7.3%
Q3 25
8.4%
Q2 25
10.4%
Q1 25
5.8%
Q4 24
5.9%
Q3 24
7.4%
Q2 24
9.8%
Q1 24
10.6%
EPS (diluted)
BDX
BDX
NIVF
NIVF
Q4 25
$1.34
Q3 25
$1.71
Q2 25
$2.00
Q1 25
$1.07
Q4 24
$1.04
Q3 24
$1.37
Q2 24
$1.68
Q1 24
$1.85

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons